Skip to content

The efficacy of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a pilot study.

The efficacy of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a pilot study. - walk-bike IPF

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41589
Enrollment
11
Registered
2014-04-03
Start date
2014-04-23
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung fibrosis scarring of the long

Interventions

The intervention is use of a walk-bike in daily life during 8 weeks, with a minimum of 1 hour per day. The patient will be asked to record the time using the walk-bike in a diary. At baseline instru

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -IPF patients -Diagnosis of IPF, including probable and possible diagnosis according to ATS/ERS criteria -Written informed consent -TLCOc >= 25% (pred) and FVC >= 50% (pred) -6MWD >= 150 m -Being clinically stable -Absolute decline in TLCOc and FVC should be less than 10% in the past 6 months.

Exclusion criteria

Exclusion criteria: -Participation in a formal rehabilitation program within 4 months of start of study -Musculoskeletal disorders -Severe cardiac diseases (ejection fraction

Design outcomes

Primary

MeasureTime frame
Change in total score in health-related quality of life questionnaire SGRQ , measured at week 9 and week 18 compared to baseline.

Secondary

MeasureTime frame
Change in exercise capacity measures at week 9 and week 18 compared to baseline (distance (m) during 6-minute-walk-test and average steps per day) Change in score in health related quality of life questionnaires K-BILD abd GAD-7 , measured at 9 and 18 weeks compared with baseline. This questionnaire is self-administered. Change in component scores (symptoms, activity and impact) in health-related quality of life measured with SGRQ at week 9 and 18 compared to baseline.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)